Analyst Ratings for Acadia Pharmaceuticals (ACAD) [Buys]
ACAD Rating Summary
ACAD Price Target Summary
- Highest: $19.00 (Piper Jaffray)
- Lowest: $3.00 (Roth Capital)
- Average: $12.40
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$12.40 (-10.1%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/11/2013 | Piper Jaffray | Upgrade | Overweight (Neutral) |
19.00 (5.00) |
7.97 | 13.79 | 73.02% | Details |
| 3/19/2013 | Jefferies » Updated 5/6/2013 |
New Coverage | Buy (N/A) |
18.00 (N/A) |
6.18 | 13.79 | 123.14% | Details |
| 1/28/2013 | Cowen | New Coverage | Outperform (N/A) |
N/A (N/A) |
6.19 | 13.79 | 122.78% | Details |
| 11/27/2012 | Needham & Company » Updated 5/8/2013 |
Upgrade | Buy (Hold) |
16.00 (N/A) |
5.50 | 13.79 | 150.73% | Details |
| 6/15/2012 | SunTrust Robinson Humphrey | New Coverage | Buy (N/A) |
6.00 (N/A) |
1.39 | 13.79 | 892.09% | Details |
| 5/24/2012 | Roth Capital | New Coverage | Buy (N/A) |
3.00 (N/A) |
1.45 | 13.79 | 851.03% | Details |
| 4/30/2012 | Ladenburg Thalmann | New Coverage | Buy (N/A) |
N/A (N/A) |
1.51 | 13.79 | 813.25% | Details |
